TY - JOUR AU - Soda, M. AU - Choi, Y. L. AU - Enomoto, M. AU - Takada, S. AU - Yamashita, Y. AU - Ishikawa, S. PY - 2007 DA - 2007// TI - Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05945 DO - 10.1038/nature05945 ID - Soda2007 ER - TY - JOUR AU - Solomon, B. AU - Varella-Garcia, M. AU - Camidge, D. R. PY - 2009 DA - 2009// TI - ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer JO - J Thorac Oncol VL - 4 UR - https://doi.org/10.1097/JTO.0b013e3181c4dedb DO - 10.1097/JTO.0b013e3181c4dedb ID - Solomon2009 ER - TY - JOUR AU - Camidge, D. R. AU - Bang, Y. J. AU - Kwak, E. L. AU - Iafrate, A. J. AU - Varella-Garcia, M. AU - Fox, S. B. PY - 2012 DA - 2012// TI - Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70344-3 DO - 10.1016/S1470-2045(12)70344-3 ID - Camidge2012 ER - TY - JOUR AU - Camidge, D. AU - Ou, S. AU - Shapiro, G. AU - Otterson, G. AU - Villaruz, L. AU - Villalona-Calero, M. PY - 2014 DA - 2014// TI - Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC) JO - J Clin Oncol VL - 32 ID - Camidge2014 ER - TY - JOUR AU - Shaw, A. T. AU - Ou, S. -. H. I. AU - Bang, Y. -. J. AU - Camidge, D. R. AU - Solomon, B. J. AU - Salgia, R. PY - 2014 DA - 2014// TI - Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1406766 DO - 10.1056/NEJMoa1406766 ID - Shaw2014 ER - TY - JOUR AU - Solomon, B. J. AU - Mok, T. AU - Kim, D. -. W. AU - Wu, Y. -. L. AU - Nakagawa, K. AU - Mekhail, T. PY - 2014 DA - 2014// TI - First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1408440 DO - 10.1056/NEJMoa1408440 ID - Solomon2014 ER - TY - JOUR AU - Ou, S. H. AU - Janne, P. A. AU - Bartlett, C. H. AU - Tang, Y. AU - Kim, D. W. AU - Otterson, G. A. PY - 2014 DA - 2014// TI - Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt572 DO - 10.1093/annonc/mdt572 ID - Ou2014 ER - TY - STD TI - FDA. Crizotinib Label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202570s006lbl.pdf. UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202570s006lbl.pdf ID - ref8 ER - TY - JOUR AU - Lin, Y. -. T. AU - Wang, Y. -. F. AU - Yang, J. C. -. H. AU - Yu, C. -. J. AU - Wu, S. -. G. AU - Shih, J. -. Y. PY - 2014 DA - 2014// TI - Development of renal cysts after crizotinib treatment in advanced ALK-positive non–small-cell lung cancer JO - J Thoracic Oncol VL - 9 UR - https://doi.org/10.1097/JTO.0000000000000326 DO - 10.1097/JTO.0000000000000326 ID - Lin2014 ER - TY - STD TI - Schnell P, Bartlett CH, Solomon BJ, Tassell V, Shaw AT, Pas T et al. Complex renal cysts associated with crizotinib treatment. Cancer Med. 2015;4(6):887–96. ID - ref10 ER - TY - JOUR AU - Klempner, S. J. AU - Aubin, G. AU - Dash, A. AU - Ou, S. PY - 2014 DA - 2014// TI - Spontaneous regression of crizotinib-associated complex renal cysts during continuous crizotinib treatment JO - Oncologist VL - 19 UR - https://doi.org/10.1634/theoncologist.2014-0216 DO - 10.1634/theoncologist.2014-0216 ID - Klempner2014 ER - TY - JOUR AU - Baert, L. AU - Steg, A. PY - 1977 DA - 1977// TI - On the pathogenesis of simple renal cysts in the adult. A microdissection study JO - Urol Res VL - 5 UR - https://doi.org/10.1007/BF00256861 DO - 10.1007/BF00256861 ID - Baert1977 ER - TY - STD TI - Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol. 2003;58:626–29. ID - ref13 ER - TY - JOUR AU - Terada, N. AU - Arai, Y. AU - Kinukawa, N. AU - Terai, A. PY - 2008 DA - 2008// TI - The 10-year natural history of simple renal cysts JO - Urology VL - 71 UR - https://doi.org/10.1016/j.urology.2007.07.075 DO - 10.1016/j.urology.2007.07.075 ID - Terada2008 ER - TY - JOUR AU - Warren, K. S. AU - McFarlane, J. PY - 2005 DA - 2005// TI - The Bosniak classification of renal cystic masses JO - BJU Int VL - 95 UR - https://doi.org/10.1111/j.1464-410X.2005.05442.x DO - 10.1111/j.1464-410X.2005.05442.x ID - Warren2005 ER - TY - JOUR AU - Whelan, T. F. PY - 2010 DA - 2010// TI - Guidelines on the management of renal cyst disease JO - Can Urol Assoc J VL - 4 UR - https://doi.org/10.5489/cuaj.10023 DO - 10.5489/cuaj.10023 ID - Whelan2010 ER - TY - JOUR AU - Curry, N. S. AU - Cochran, S. T. AU - Bissada, N. K. PY - 2000 DA - 2000// TI - Cystic renal masses: accurate Bosniak classification requires adequate renal CT JO - AJR Am J Roentgenol VL - 175 UR - https://doi.org/10.2214/ajr.175.2.1750339 DO - 10.2214/ajr.175.2.1750339 ID - Curry2000 ER - TY - JOUR AU - Carvalho, L. AU - Shimada, A. AU - Cruz Neto, M. AU - Silva Rocha, L. AU - Viana, P. AU - Kallas, E. AU - Katz, A. PY - 2015 DA - 2015// TI - Development of aseptic renal abscess in a patient with non-small-cell lung cancer with ALK translocation during Crizotinib treatment JO - Adv Lung Cancer VL - 4 UR - https://doi.org/10.4236/alc.2015.44007 DO - 10.4236/alc.2015.44007 ID - Carvalho2015 ER - TY - JOUR AU - Chan, W. Y. AU - Ang, M. K. AU - Tan, D. S. AU - Koh, W. L. AU - Kwek, J. W. PY - 2016 DA - 2016// TI - Imaging features of renal complications after crizotinib treatment for non-small-cell lung cancer: a case report JO - Radiol Case Rep VL - 11 UR - https://doi.org/10.1016/j.radcr.2016.04.010 DO - 10.1016/j.radcr.2016.04.010 ID - Chan2016 ER - TY - JOUR AU - Yoneshima, Y. AU - Okamoto, I. AU - Arimura-Omori, M. AU - Kimura, S. AU - Hidaka-Fujimoto, N. AU - Iwama, E. PY - 2015 DA - 2015// TI - Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement JO - Invest New Drugs VL - 33 UR - https://doi.org/10.1007/s10637-014-0195-1 DO - 10.1007/s10637-014-0195-1 ID - Yoneshima2015 ER - TY - JOUR AU - Wu, J. AU - Savooji, J. AU - Liu, D. PY - 2016 DA - 2016// TI - Second- and third-generation ALK inhibitors for non-small cell lung cancer JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0251-8 DO - 10.1186/s13045-016-0251-8 ID - Wu2016 ER - TY - JOUR AU - Horie, S. AU - Higashihara, E. AU - Nutahara, K. AU - Mikami, Y. AU - Okubo, A. AU - Kano, M. PY - 1994 DA - 1994// TI - Mediation of renal cyst formation by hepatocyte growth factor JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)92344-2 DO - 10.1016/S0140-6736(94)92344-2 ID - Horie1994 ER - TY - JOUR AU - Jayapalan, S. AU - Saboorian, M. H. AU - Edmunds, J. W. AU - Aukema, H. M. PY - 2000 DA - 2000// TI - High dietary fat intake increases renal cyst disease progression in Han: SPRD-cy rats JO - J Nutr VL - 130 ID - Jayapalan2000 ER - TY - JOUR AU - Cowley, B. D. AU - Rupp, J. C. AU - Muessel, M. J. AU - Gattone, V. H. PY - 1997 DA - 1997// TI - Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats JO - Am J Kidney Dis VL - 29 UR - https://doi.org/10.1016/S0272-6386(97)90039-1 DO - 10.1016/S0272-6386(97)90039-1 ID - Cowley1997 ER - TY - JOUR AU - Weickhardt, A. J. AU - Rothman, M. S. AU - Salian-Mehta, S. AU - Kiseljak-Vassiliades, K. AU - Oton, A. B. AU - Doebele, R. C. PY - 2012 DA - 2012// TI - Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.27450 DO - 10.1002/cncr.27450 ID - Weickhardt2012 ER -